Pipeline & Platform

PT010

PT010 is a triple-drug combination of the long-acting muscarinic antagonist (LAMA) glycopyrronium, the long acting β2-agonist (LABA) formoterol fumarate and budesonide, an inhaled corticosteroid (ICS). As with Pearl’s monotherapy and dual therapy Co-SuspensionTM delivery technology product candidates, PT010 is delivered via a standard MDI.